Excerpt: “The impact of the bill may also ricochet into next years’ legislative priorities for health care and environmental lobbyists. Vincent DeMarco, president of Maryland Health Care for All, said that a measure in the bill that allows Medicare to negotiate prices with pharmaceutical companies will be an asset in achieving the organization’s goals.
“Our priority at Health Care for All is going to be to give the Prescription Drug Affordability Board the authority it needs to make high-cost drugs more affordable for everybody. This bill helps because when Medicare negotiates with the drug companies and sets what they’re going to pay … that can be guidance on, what are upper payment limits?” he said, echoing Miller. “This law protects everybody on Medicare. We’re going to expand that to all Marylanders.”
See the full article on the Daily Record’s website.Last modified: August 15, 2022